8-K filing — Apimeds Pharmaceuticals US, Inc. (APUS)
Filed: 2026-08-21 AccNo: 0001213900-26-092680 Size: 6 MB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Read original at edgarFilings · News reference
Apimeds Pharmaceuticals US Enters Assignment And Transfer Agreement With Freet On Aug 19, 2026; Freet Assigns All Apitox-Related Rights To Apimeds Pharmaceuticals; Receives 100% Korean Clinic Rights, 25% U.S. Royalty, 25% Overseas Revenue Participation For Apitox
-SEC Filing
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 21, 2026, 9:17 PM
- Checked
- Aug 21, 2026, 9:17 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Tenon Medical (NASDAQ:TNON) shares moved upwards by 70.3% to $9.28 during Tuesday's after-market session. The market value of their outstanding shares is at $3.2 million. The company's, Q2 earnings came
Read original at benzinga12 Health Care Stocks Moving In Monday's After-Market Session
Gainers INVO Fertility (NASDAQ:IVF) stock moved upwards by 13.1% to $1.73 during Monday's after-market session. The company's market cap stands at $1.7 million. The company's, Q2 earnings came out today.
Read original at benzinga